文献速递MDS 与骨髓增殖性肿瘤

MECOM、HBS1L-MYB、THRB-RARB、JAK2 和 TERT 基因多态性界定骨髓增殖性肿瘤的遗传易感性:一项针对 939 例患者的研究

MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients.
PubMed 文献 · Am J Hematol · 2017-11-10

研究在 939 例骨髓增殖性肿瘤(MPN)患者(454 例 ET、337 例 PV、148 例 PMF)和 483 例对照中检测 MECOM rs2201862、HBS1L-MYB rs9376092、THRB-RARB rs4858647、JAK2 46/1 和 TERT rs2736100 多态性,发现 JAK2 46/1、TERT rs2736100 和 MECOM rs2201862 是 MPN 的主要易感多态性。

要点

  • MECOM rs2201862 与除 ET 外的各 MPN 类型及主要分子亚型显著相关,CALR 突变者 OR=1.4(95%CI 1.1-1.8,P=.005)。
  • HBS1L-MYB rs9376092 仅与 JAK2 V617F 突变 ET 相关,OR=1.4(95%CI 1.1-1.7,P=.003)。
  • JAK2 46/1 单倍型与 CALR 突变 MPN 亦显著相关,OR=1.4(95%CI 1.1-1.8,P=.01)。

核心结论

  • JAK2 46/1、TERT rs2736100 和 MECOM rs2201862 是 MPN 的主要易感多态性。

研究设计与样本

  • 研究对 939 例 MPN 患者(454 例 ET、337 例 PV、148 例 PMF)和 483 例对照进行基因分型,检测 MECOM rs2201862、HBS1L-MYB rs9376092、THRB-RARB rs4858647、JAK2 46/1 和 TERT rs2736100。

主要发现

  • MECOM rs2201862 与除 ET 外的各 MPN 类型及所有主要分子亚型显著相关,尤其 CALR 突变者 OR=1.4(95%CI 1.1-1.8,P=.005)。
  • HBS1L-MYB rs9376092 仅与 JAK2 V617F 突变 ET 相关,OR=1.4(95%CI 1.1-1.7,P=.003)。
  • THRB-RARB rs4858647 仅与 PMF 弱相关,OR=1.5(95%CI 1-2.1,P=.04)。
  • JAK2 46/1 单倍型不仅与 JAK2 V617F 突变 MPN 显著相关,也与 CALR 突变 MPN 相关,OR=1.4(95%CI 1.1-1.8,P=.01)。
  • TERT rs2736100 与所有 MPN 无论表型或分子亚型均同等强度相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are classical myeloproliferative neoplasms (MPN), characterized by specific somatic mutations in JAK2, CALR or MPL genes. JAK2 46/1 and TERT rs2736100 polymorphisms are known to significantly predispose to MPN. This study aimed to establish the additional contribution of the recently described MECOM rs2201862, HBS1L-MYB rs9376092 and THRB-RARB rs4858647 polymorphisms to the occurrence of MPN. These three polymorphisms, along with JAK2 46/1 and TERT rs2736100 were genotyped in 939 MPN patients (454 with ET, 337 with PV and 148 with PMF) and 483 controls. MECOM rs2201862 associated significantly with each MPN entity, except for ET, and with all major molecular sub-types, especially those CALR-mutated (OR = 1.4; 95% CI = 1.1-1.8; P-value = .005). HBS1L-MYB rs9376092 associated only with JAK2 V617F-mutated ET (OR = 1.4; 95% CI = 1.1-1.7; P-value = .003). THRB-RARB rs4858647 had a weak association with PMF only (OR = 1.5; 95% CI = 1-2.1; P-value = .04). Surprisingly, JAK2 46/1 haplotype was associated significantly not only with JAK2 V617F-mutated MPN, but also with CALR-mutated MPN (OR = 1.4; 95% CI = 1.1-1.8; P-value = .01). TERT rs2736100 was associated equally strong with all MPN, regardless of phenotype or molecular sub-type. In conclusion, JAK2 46/1, TERT rs2736100 and MECOM rs2201862 are the chief predisposing polymorphisms to MPN.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Trifa AP, Bănescu C, Bojan AS, et al. MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients. Am J Hematol. 2017. PMID: 29047144. doi:10.1002/ajh.24946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。